Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 ‘RADAR’ trial clinical data-Reference-Cited by-同舟云学术

Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 ‘RADAR’ trial clinical data

Published:2015-10 Issue:6 Volume:47 Page:520-525
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Delahunt B.,Egevad L.,Srigley J.R.,Steigler A.,Murray J.D.,Atkinson C.,Matthews J.,Duchesne G.,Spry N.A.,Christie D.,Joseph D.,Attia J.,Denham J.W.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference33 articles.

1. Gleason grading: past, present and future;Delahunt;Pathology,2012

2. Classification of prostatic carcinoma;Gleason;Cancer Chemother Rep,1966

3. Prediction of prognosis for prostatic adeno-carcinoma by combined histological grading and clinical staging;Gleason;J Urol,1974

4. Histologic grading of prostate cancer: a perspective;Gleason;Hum Pathol,1992

5. Prostate cancer: the new evidence base for diagnosis and treatment;Lamb;Pathology,2007

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients;Pathology;2023-11

2. International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial;BJU International;2023-08-07

3. Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial;Pathology;2022-02

4. Comparative study between 1.5 and 3 Tesla multiparametric MRI systems using the PIRADS version 2 classification in the diagnosis of prostate cancer;Archivos Españoles de Urología;2022

5. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade;Clinical Epidemiology;2022-01